Into clinical practice:

Meeting the challenges of Gram-negative infection management

19 November 2019

Royal college of Physicians, London

Welcome to this exciting one day conference which will explore the current challenges and treatment opportunities for Gram-negative infections.

Delegates will, through plenary lectures and invited papers, learn about resistance mechanisms, clinical presentations of Gram-negative infections, the latest in research and development and hear about frontier and upcoming treatments.

Clinical lessons will give delegates the opportunity to hear about, share and explore real world experiences, and look at the effective application of the latest evidence based guidelines.

Don’t miss this opportunity to update your knowledge and network with colleagues across all sectors.

We look forward to seeing you in November.

Programme

0845
Registration and refreshments
0930
Opening remarks
Professor Philip Howard Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals and University of Leeds

SESSION ONE: The helicopter view
Chair: Professor Philip Howard Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals and University of Leeds
0935
Global and UK epidemiology of Gram-negative infections
Dr Susan Hopkins, Healthcare-Associated Infection & Antimicrobial Resistance Division, Deputy Director, National Infection Service, Public Health England
1000
Understanding resistance mechanisms and their applications into practice
Professor Peter Hawkey, Professor of Clinical and Public Health Bacteriology, University of Birmingham
1025
Drug R&D to combat Gram-negative infections
Dr David Roblin, CEO Summit Therapeutics

1050
Refreshments and posters

SESSION TWO: The patient and the bacteria
Chair: Dr Susan Hopkins, Healthcare-Associated Infection & Antimicrobial Resistance Division, Deputy Director, National Infection Service, Public Health England
1120
Clinical presentations and impact of Gram-negative infections
Dr Gavin Barlow Consultant in Infection, Hull & East Yorkshire Hospitals NHS Trust and Hon. Senior Clinical Lecturer, Hull York Medical School
1140
PK-PD challenges for Gram-negative infections
Professor William Hope, Professor of Therapeutics and Infectious Diseases, University of Liverpool
1200
Advances in betalactamase inhibition in difficult to treat infections
Dr Shampa Das, Senior Lecturer, University of Liverpool
1220
Supported presentation: Appropriate diagnostics as an aid in the fight against AMR
Gioia Babini, Senior Scientific Affairs Manager, BD Life Science
1240
Invited paper: Compassionate use of Cefiderocol for Multi-drug resistant Acinetobacter baumannii orthopaedic infection following surgery in Pakistan
Dr Diana A Mabayoje, Microbiology SpR, Homerton Hospital

1300
Lunch, posters and interactive sessions

SESSION THREE: Supported Session: Menarini – The Gram-Negative Challenge
Chair: Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee
1345
Introduction
Professor Dilip Nathwani OBE, Director, Academic Health Sciences Partnership [AHSP] in Tayside and Honorary Professor of Infection, Ninewells Hospital and Medical School, Dundee
1350
Introduction to the challenges of treating multi-drug resistant gram-negative infections
Professor Peter Hawkey, Institute of Microbiology and Infection (IMI), University of Birmingham
1405
New and emerging therapies for serious gram-negative infections
Dr Ryan Shields, Associate Professor, University of Pittsburgh
1425
Interactive Debate

SESSION FOUR: Optimal use of new gram negatives – do we need to challenge the patient pathway?
1445
Panel discussion

SESSION FIVE: Real world experience – managing resistance in practice
1530
Effects of an outbreak: Outcomes
Dr Andrew Dodgson, Consultant Microbiologist, Central Manchester University Hospitals NHS Foundation Trust
1545
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries
Dr Jon Otter, Honorary Senior Lecturer, Imperial College London
1615
Closing remarks

Registration

We encourage you to register, submit abstracts and join us in what promises to be another innovative and exciting conference.

By signing up to the BSAC’s MySociety membership portal this allows you to manage your details and preferences, book courses and conferences and much more.

For queries regarding registration, please contact Esme Carruthers at Ecarruthers@bsac.org.uk

Standard - Member  £120

Standard – non-member  £160

Pharmacist/Nurse (member)  £80

Pharmacist/Nurse (non-member)  £100

Trainee (member)  £60

Trainee (non-member)  £80

Student (member)  £40

Student (non-member)  £60

For an alternative way to register please download the registration form here.

Download Reg Form
 

Commercial registrations rates (Members and non-members): Please contact debbie@pagemedical.co.uk

Abstracts

BSAC ARE PLEASED TO INVITE YOU TO SUBMIT YOUR ABSTRACT OR POSTER FOR CONSIDERATION FOR THE INTO CLINICAL PRACTICE: MEETING THE CHALLENGES OF GRAM-NEGATIVE INFECTION MANAGEMENT CONFERENCE

Abstract submission for the Into Clinical Practice: Meeting the Challenges of Gram-negative Infection Management is now OPEN.

Please note that the date for oral presentation submissions closes on 20th September with final submissions for posters being 25th October.

To review the guidance, download templates and submit your abstracts, please sign up to the BSAC’s MySociety membership portal.

PLEASE NOTE: ACCEPTED POSTER PRESENTATIONS SHOULD BE PRINTED IN SIZE A0, PORTRAIT ORIENTATION ONLY.

MySociety sign up

Sponsors

We have a number of sponsorship packages available to suit individual company needs.

For more information please contact Debbie Cockayne at debbie@pagemedical.co.uk

Conferences, conventions, exhibitions, award dinners and corporate events

An exceptional award-winning conference and events centre
For information on the venue and travel please visit the RCP website


© Copyright 2019
British Society for Antimicrobial Chemotherapy.

By using this site, you agree to using cookies. For more details about cookies and how to disable them, see our cookie page